Leritone Genius 2- Leritone Études 2- Leritone cerveau 2- Leritone Santé cognitive 2- ABC 2- ADR 2- ADD
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Anchois, sardines et maquereaux: Chair de poisson Potency : 250 milligramme EPA | 500 milligramme | Not calculated |
| Huile de poisson Source : Anchois, sardines et maquereaux: Chair de poisson Potency : 100 milligramme DHA | Not specified | Not calculated |
| Oenothera biennis Source : Graine(s) Potency : 10 milligramme Acide gamma-linoléique(AGL) | 100 milligramme | Not calculated |
| Lécithine de poisson Source : Poissons pélagiques sauvages: Chair de poisson Potency : 25 milligramme phospholipides de poisson | 41.7 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Gélatine, Acétate de tocophérol, Ethyl Vanillin, Extrait de caroube, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants (46-55kg) | minimum: 8 years ; maximum: 15 years | 2 Capsule | 1 Tous les jours |
| Enfants (26-35kg) | minimum: 8 years ; maximum: 15 years | 2 Capsule | 1 Tous les jours |
| Enfants (26-35kg) | minimum: 8 years ; maximum: 15 years | 1 Capsule | 1 Tous les jours |
| Enfants (36-45kg) | minimum: 8 years ; maximum: 15 years | 2 Capsule | 2 Tous les jours |
| Enfants (46-55kg) | minimum: 8 years ; maximum: 15 years | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Améliore les niveaux de concentration chez les enfants de moins de 15 ans souffrant de trouble de l'attention avec ou sans hyperactivité. (TDA ou TDAH) Pourrait aider dans la prise en charge du TDA et du TDAH / May help in the management of ADD/ADHD. Aide à la concentration chez les enfants de moins de 15 ans souffrant de TDAH. Aide à contrôler les symptômes de TDA chez les enfants de 15 ans et moins. Supporte la santé cognitive et les fonctions cérébrales. Supporte le développement du cerveau, des yeux et des nerfs chez les enfants âgés de 12 ans et moins. Aide au développement du système nerveux.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Product record
- Other names
- Leritone TDAH-ADHD
- Licence holder
- IRB Yves Ponroy Canada Inc.
- NPN or DIN-HM
- 80061868
- Status
- Active licence
- Licence date
- 15 June 2015
- Revision date
- 9 October 2015
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80061868
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
- Oenothera biennis
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Leritone Genius 2- Leritone Études 2- Leritone cerveau 2- Leritone Santé cognitive 2- ABC 2- ADR 2- ADD”, https://compoatlas.com/en/supplements/canada/80061868-leritone-genius-2-leritone-etudes-2-leritone-cerveau-2-lerit, updated 9 October 2015.